Invesco
IVZ
26.51
-1.26
-4.54%
Invesco
US · IVZ
#1217 by market cap
Listed 1970
26.51
-1.26
-4.54%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 34 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 97.89% -0.09pp
- Institutions
- 831 +34
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund59.52%
Private Company20.29%
Hedge Fund10.79%
Public Company3.76%
Government Pension Fund1.57%
Sovereign Wealth Fund1.19%
Individual/Insider0.69%
Family Office/Trust0.31%
Insurance Company0.29%
Other1.59%
Top holders as of 2026-02-17
Massachusetts Mutual Life Insurance Company
18.52% · 81.41M sh
BlackRock
8.81% · 38.71M sh
Vanguard Capital Management, LLC
6.95% · 30.57M sh
Dimensional Fund Advisors
4.74% · 20.82M sh
Vanguard Portfolio Management, LLC
4.20% · 18.46M sh
State Street Global Advisors
3.82% · 16.79M sh
Millennium Management LLC
3.57% · 15.69M sh
Geode Capital Management, LLC
2.82% · 12.40M sh
AQR Capital Management
2.80% · 12.33M sh
T. Rowe Price Group, Inc.
2.42% · 10.62M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 29 buys · 21 sells
| Name | Role | Stake |
|---|---|---|
| Massachusetts Mutual Life Insurance Company | -- | 18.52% |
| Andrew Tak Lo | Senior MD & Head of Asia Pacific | 0.18% |
| Andrew Schlossberg | Chief Executive Officer | 0.17% |
| Laura Dukes | Senior MD & CFO | 0.06% |
| Tony Wong | Senior MD & Co-Head of Investments | 0.03% |
| Jeffrey Kupor | Senior MD & General Counsel | 0.03% |
| G. Wagoner | Chair of the Board | 0.03% |
| Sarah Beshar | Independent Non-Executive Director | 0.03% |
| Phoebe Wood | Independent Non-Executive Director | 0.02% |
| Nigel Sheinwald | Independent Non-Executive Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-15 | Shannon Johnston | Senior MD & Chief Information and Operations Officer | Derivative Exercise and Sale | -12,526 | $28.20 |
| 2026-10-15 | Shannon Johnston | Senior MD & Chief Information and Operations Officer | Derivative Exercise and Retained | +15,723 | -- |
| 2026-09-10 | Phoebe Wood | Independent Non-Executive Director | Open Market Disposition | -3,000 | $32.44 |
| 2026-09-08 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Open Market Disposition | -143,370 | $32.20–32.85 |
| 2026-09-08 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Intent to Sell (Form 144) | -100,840 | $32.20 |
| 2026-09-08 | Stephanie Butcher | Senior MD & Co-Head of Investment | Open Market Disposition | -45,095 | $32.28 |
| 2026-09-07 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Intent to Sell (Form 144) | -42,530 | $32.85 |
| 2026-09-03 | Laura Dukes | Senior MD & CFO | Other Disposition | -7,600 | -- |
| 2026-09-03 | Laura Dukes | Senior MD & CFO | Open Market Disposition | -31,075 | $33.16 |
| 2026-08-30 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Sale | -30,760 | $32.78 |
| 2026-08-30 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Retained | +34,682 | -- |
| 2026-08-30 | Douglas Sharp | Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK | Derivative Exercise and Sale | -22,213 | $32.78 |
| 2026-08-30 | Douglas Sharp | Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK | Derivative Exercise and Retained | +48,272 | -- |
| 2026-07-01 | Jeffrey Kupor | Senior MD & General Counsel | Sale to Issuer | -26,002 | $27.01 |
| 2026-07-01 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Derivative Exercise and Retained | +116,754 | -- |
| 2026-07-01 | Andrew Schlossberg | Chief Executive Officer | Sale to Issuer | -156,007 | $27.01 |
| 2026-07-01 | Laura Dukes | Senior MD & CFO | Sale to Issuer | -52,003 | $27.01 |
| 2026-05-14 | G. Wagoner | Chair of the Board | Other Acquisition | +8,112 | -- |
| 2026-05-14 | Thomas Finke | Independent Non-Executive Director | Other Acquisition | +8,112 | -- |
| 2026-05-14 | William Glavin | Independent Non-Executive Director | Other Acquisition | +8,112 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Invesco discussion 0 comments